LRRK2 and inflammatory bowel disease: Previous studies have implicated LRRK2 polymorphisms in autoinflammatory diseases including inflammatory bowel disease (IBD), Crohn’s disease, and tuberculosis, indicating a significant connection to immune functions [27].